Literature DB >> 10551320

Prevention of lung metastasis by intra-tumoral injection of Cepharanthin and staphylococcal enterotoxin B in transplantable rat osteosarcoma.

K Okada1, N Sakusabe, A Kobayashi, N Hoshi, K Sato.   

Abstract

The antitumor effect of intra-tumoral injection of Cepharanthin, a biscoclaurin alkaloid extracted from Stephania cephalanta Hayata, and staphylococcal enterotoxin B was evaluated using F344 male rats bearing transplantable rat osteosarcoma, S-SLM. A macroscopic lung metastatic nodule of tumor was transplanted into the subcutaneous back space, and 0.5 mg of Cepharanthin and 2 pg of staphylococcal enterotoxin B were injected into the tumor on days 12, 13 and 14. On day 28, all animals were killed with an overdose of pentobarbital sodium, and the transplanted tumors and lungs were examined. The wet weight of the lungs of the rats treated with Cepharanthin and staphylococcal enterotoxin B was significantly lower, and apoptosis in the lung metastatic nodules was significantly higher than that of the control or that of rats treated with only Cepharanthin or staphylococcal enterotoxin B. In the transplanted tumors, infiltration of TRAP (tartrate-resistant acid phosphatase)-positive multinucleated giant cells was prominent in the rats treated with Cepharanthin and staphylococcal enterotoxin B. These findings indicate that intra-tumoral injection of Cepharanthin and staphylococcal enterotoxin B induced infiltration of TRAP-positive multinucleated giant cells within the transplanted rat osteosarcoma, and reduced lung metastasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551320      PMCID: PMC5926173          DOI: 10.1111/j.1349-7006.1999.tb00837.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Antitumor effect of bisbenzylisoquinoline alkaloids.

Authors:  H Kuroda; S Nakazawa; K Katagiri; O Shiratori; M Kozuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-10       Impact factor: 1.645

Review 2.  Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis.

Authors:  I J Fidler
Journal:  Res Immunol       Date:  1992-02

3.  Acid phosphatase activity is detected preferentially in the osteoclastic lineage by pre-treatment with cyanuric chloride.

Authors:  Y Nakamura; A Yamaguchi; T Ikeda; S Yoshiki
Journal:  J Histochem Cytochem       Date:  1991-10       Impact factor: 2.479

4.  Macrophages and metastasis--a biological approach to cancer therapy.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

5.  Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis.

Authors:  S Furusawa; J Wu; T Fujimura; S Nakano; S Nemoto; M Takayanagi; K Sasaki; Y Takayanagi
Journal:  Methods Find Exp Clin Pharmacol       Date:  1998-03

6.  Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.

Authors:  K Honoki; M Tsutsumi; Y Miyauchi; Y Mii; T Tsujiuchi; T Morishita; S Miura; M Aoki; E Kobayashi; S Tamai
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Tartrate-resistant acid phosphatase as a differentiation marker for the human mononuclear phagocyte system.

Authors:  H J Radzun; H Kreipe; M R Parwaresch
Journal:  Hematol Oncol       Date:  1983 Oct-Dec       Impact factor: 5.271

8.  Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.

Authors:  J Asaumi; K Nishikawa; H Matsuoka; M Iwata; S Kawasaki; Y Hiraki; K Nishijima
Journal:  Anticancer Res       Date:  1995 Jan-Feb       Impact factor: 2.480

9.  Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.

Authors:  J Vaage; K G Pepin
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

10.  Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.

Authors:  M Hirai; K Tanaka; T Shimizu; Y Tanigawara; M Yasuhara; R Hori; Y Kakehi; O Yoshida; K Ueda; T Komano
Journal:  J Pharmacol Exp Ther       Date:  1995-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.